Skip to main content

Cancer: Drugs

Volume 479: debated on Monday 1 September 2008

To ask the Secretary of State for Health when the National Cancer Director plans to publish his report on the uptake of cancer drugs approved by the National Institute for Health and Clinical Excellence, as referred to in paragraph 4.51 of his Department’s Cancer Reform Strategy. (220958)

Work on the report is now under way and it is anticipated that it will be published by the end of the year.

To ask the Secretary of State for Health what steps have been taken by his Department with the (a) pharmaceutical and (b) biotechnology industries to monitor how use of anti-cancer medicines in the NHS in England compares to other European countries; what the results of this work have been; and if he will make a statement. (220962)

As part of the innovation package arising from the negotiations on a new Pharmaceutical Price Regulation Scheme, the Government have committed to the development of new metrics for the uptake of clinically and cost-effective medicines starting with a number of medicines, including anti-cancer medicines, positively appraised by the National Institute for Health and Clinical Excellence, and to the publication of comparative international data.